For the quarter ended September 2025, Coty (COTY) reported revenue of $1.58 billion, down 5.6% over the same period last year. EPS came in at $0.12, compared to $0.15 in the year-ago quarter.
The reported revenue represents a surprise of -0.35% over the Zacks Consensus Estimate of $1.58 billion. With the consensus EPS estimate being $0.15, the EPS surprise was -20%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Coty performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Revenues- Prestige: $1.07 billion versus $1.07 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -4% change.
- Net Revenues- Consumer Beauty: $507.7 million compared to the $514.7 million average estimate based on four analysts. The reported number represents a change of -8.9% year over year.
- Adjusted Operating Income (Loss)- Prestige: $239 million compared to the $242.77 million average estimate based on two analysts.
- Adjusted Operating Income (Loss)- Consumer Beauty: $1.5 million versus the two-analyst average estimate of $-1.58 million.
View all Key Company Metrics for Coty here>>>
Shares of Coty have returned -5.7% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Coty (COTY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
